Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 104,213 | 87,842 | 102,760 | 93,205 | 102,330 |
| Cost of Goods | 31,479 | 28,750 | 33,628 | 28,575 | 32,344 |
| Gross Profit | 72,734 | 59,092 | 69,132 | 64,630 | 69,986 |
| Operating Expenses | 97,004 | 92,611 | 95,975 | 111,649 | 86,093 |
| Operating Income | -23,791 | -32,769 | -26,215 | -46,444 | -15,763 |
| Interest Expense | 1,608 | 1,603 | 3,810 | 3,688 | 5,704 |
| Other Income | 650 | 228 | -187 | 129 | 75 |
| Pre-tax Income | -24,749 | -34,144 | -30,212 | -50,003 | -21,392 |
| Income Tax | 241 | 181 | -78 | 72 | 198 |
| Net Income Continuous | -24,990 | -34,325 | -30,134 | -50,075 | -21,590 |
| Net Income | $-24,990 | $-34,325 | $-30,134 | $-50,075 | $-21,590 |
| EPS Basic Total Ops | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 |
| EPS Basic Continuous Ops | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 |
| EPS Diluted Total Ops | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 |
| EPS Diluted Continuous Ops | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 |
| EBITDA(a) | $-20,505 | $-29,519 | $-20,807 | $-41,568 | $-9,505 |